Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.
about
Prescribing for patients on dialysisBowel cleansing before colonoscopy: Balancing efficacy, safety, cost and patient toleranceAcute phosphate nephropathy: a cause of chronic kidney disease.Evaluation of intestinal phosphate binding to improve the safety profile of oral sodium phosphate bowel cleansing.Acute kidney injury associated with androgenic steroids and nutritional supplements in bodybuilders(†)A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropathy.Electrolyte imbalances and nephrocalcinosis in acute phosphate poisoning on chronic type 1 renal tubular acidosis due to Sjögren's syndrome.Phosphate induced crystal acute kidney injury - an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: case report and review of the literatureEffects of Bowel Preparation and Fluid Restriction in Robot-Assisted Radical Prostatectomy PatientsCarbon dioxide for gut distension during digestive endoscopy: technique and practice survey.Colon cleansing before colonoscopy: does oral sodium phosphate solution still make sense?Strategies for the preservation of residual renal function in pediatric dialysis patients.Improving the view during flexible sigmoidoscopy: a systematic review of published randomized, controlled trials comparing the use of oral bowel preparation versus enema bowel preparation.Renal risk associated with sodium phosphate medication: safe in healthy individuals, potentially dangerous in others.Prescreening with FOBT Improves Yield and Is Cost-Effective in Colorectal Screening in the Elderly.Bowel preparation prior to percutaneous ilio-sacral screw insertion: is it necessary?Massive hyperphosphatemia in a patient with neuronal intestinal dysplasia after bowel preparation with oral sodium phosphate.Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).Increased Risk of Adverse Renal Outcome Following Polyethylene Glycol Bowel Preparation Compared to Sodium Picosulfate.Emergency do not consume/do not use concentrations for blended phosphates in drinking water.Polyethylene Glycol for Small Bowel Capsule Endoscopy.Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.Risk factors for and the prevention of acute kidney injury after abdominal surgery.Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
P2860
Q26752999-457B2B1C-B00F-4FAB-BA6E-E1F507CCDBFBQ26770800-2952B8E0-D5E2-4A44-9D3C-B910CDDC0973Q34952273-413ED940-946D-4DF2-8942-CBDF856222EBQ35196150-B5A74196-1DF5-418F-8379-D8BEC6062F95Q35891549-6D5B28AE-0A2D-41C6-AF9E-697BDDCB0F35Q36468611-FC2F9988-F8AA-4529-9A50-43FFF3EBC1E4Q36589539-54BABA3A-82D0-445E-A834-A7BBC2108696Q36709540-A6A4C677-7A42-43C8-BAB3-AE408A40ACA3Q37029062-B2BFD04A-1860-4605-91BF-FEE21605F32FQ37149586-1E8A29E5-42DE-4948-B372-D5D4998716F4Q37223176-BBF874D6-C6D1-486B-BD4C-1A4C95A2BE40Q38122625-0ED5006E-0391-4370-8A27-25272CD7CAAFQ38430541-D04BD364-F971-49DB-9E77-4911CAF13FD2Q38530466-0EAD9B0E-541B-4287-9DB2-2C786C6EAA7CQ39041941-AF8A1B12-EFA3-405C-8291-0E7B448FD11DQ39193514-A6012DA7-9AEA-41D5-B1EC-A7CBBEA03243Q39226576-73F5B9D2-4F3A-4A02-8173-22ABB5E266F5Q39995261-8BB54018-D929-4E36-8205-BB1221A401F1Q41074720-4B15C5F7-0F35-4CFB-9DAE-DE0A76E1F3E5Q43350507-00A4B449-5057-4DE7-A57C-EA7EC0B02FA1Q49618644-83337ABE-62E4-44C8-8852-C27AB89695C3Q49629769-F33C25E3-CAB1-48C9-B8DB-BE4FF9D2F049Q50100114-136A407F-7137-4260-8DCB-5AE519475C8DQ51199086-1E62A33F-0554-4F9F-8837-79BAA7D09245
P2860
Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Adverse renal and metabolic ef ...... m phosphate bowel preparation.
@ast
Adverse renal and metabolic ef ...... m phosphate bowel preparation.
@en
type
label
Adverse renal and metabolic ef ...... m phosphate bowel preparation.
@ast
Adverse renal and metabolic ef ...... m phosphate bowel preparation.
@en
prefLabel
Adverse renal and metabolic ef ...... m phosphate bowel preparation.
@ast
Adverse renal and metabolic ef ...... m phosphate bowel preparation.
@en
P2093
P2860
P356
P1476
Adverse renal and metabolic ef ...... m phosphate bowel preparation.
@en
P2093
Benjamin D Humphreys
Eliot C Heher
Helmut Rennke
Samuel O Thier
P2860
P304
P356
10.2215/CJN.02040408
P577
2008-07-02T00:00:00Z